| ATRX | Alpha-Thalassemia/intellectual Disability syndrome X-linked. |
| AUC | Area under the ROC Curve. |
| BRAF | B-Raf proto-oncogene. |
| BRCA1 | Breast cancer susceptibility gene 1. |
| BRCA2 | Breast cancer susceptibility gene 2. |
| CA125 | Carbohydrate antigen 125). |
| CDKN2A | Cyclin-dependent kinase inhibitor 2A. |
| CEA | Carcinoembryonic antigen. |
| CNN | Convolutional Neural Network. |
| CT | Computed tomography. |
| DCE | Dynamic contrast enhanced. |
| DNA | Deoxyribonucleic acid. |
| ER | Estrogen-receptor. |
| FDG PET-CT | Fluorodeoxyglucose PET/CT. |
| FLAIR | Fluid-attenuated inversion recovery. |
| GBM | Glioblastoma. |
| GSEA | Gene Set Enrichment Analysis. |
| HCC | Hepatocellular carcinoma. |
| HER2 | Human epidermal growth factor receptor 2. |
| HGSOC | High-grade serous ovarian cancer. |
| ICC | Intrahepatic cholangiocarcinoma. |
| INHBB | Inhibin subunit beta B. |
| KRAS | Carcinogenic Kirsten rat sarcoma viral oncogene homolog. |
| KEGG | Kyoto Encyclopedia of Genes and Genomes. |
| MGMT | O6-methylguanine-DNA methyltransferase. |
| NF1 | Neurofibromatosis 1. |
| PDGFRA | Platelet-derived growth factor receptor A. |
| PD-L1 | Programmed death ligand 1. |
| PET | Positron emission tomography. |
| PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha. |
| PR | Progesterone-receptor. |
| PTEN | Phosphatase and tensin homologue. |
| RB1 | Retinoblastoma protein. |
| SUV | Standardized Uptake Value. |
| TACE | Trans arterial chemoembolization. |
| TNBC | Triple-negative breast cancer. |
| TP53 | Tumor protein p53. |
| US | Ultrasound. |